"The book is a fine addition to the world of academic medical ethics... Readers... will come away with some of the tools for further debate." -- Publishers Weekly "Susan B. Rubin's splendid new book... offers positive, humane solutions to the frustrations that have given rise to the futility debate." -- Carl Elliott, Medical Humanities Review "Rubin offers a thorough and thought-provoking exploration of the concept of futility as a basis for medical decisions." -- Choice "... [the] brilliant analysis found in Rubin's [book] couldn't be more timely.... When Doctors Say No is the most thorough philosophical rebuttal to be found in the literature of medical futility as the basis for unilateral decisionmaking by physicians." -- Charles Weijer, Canadian Medical Association Journal Should physicians be permitted to unilaterally refuse to provide treatment that they deem futile? Even if the patient, or the patient's family, insists that everything possible must be done? In this book, philosopher and bioethicist Rubin examines this controversial issue. She offers a critique of the concept of medical futility and the debate surrounding it, and she calls for more public debate about the underlying issues at stake for all of us -- patients, families, health care providers, insurers, and society at large.

Man has long since sought to become something in this existence called life. He seeks to leave a legacy of remembrance and great achievement behind for generations to follow. But through the Wisdom of Solomon, as given by The Almighty God of Creation, we are to learn that all mans efforts are futile and absolute worthlessness; if God has not been made the central part of your life.

Medical futility is a controversial issue not only in its definition but also in its application. There are few books on the subject, and those in existence mostly focus on the situation in the United States. This title, however, provides extensive international perspectives on medical futility.This book will benefit healthcare professionals as well as health policy makers around the world. It allows them to see how different countries approach the issue of medical futility and their experiences in dealing with this issue. The complexity of the issue, and in particular how some countries innovatively address it in an ethically sound manner, is clearly presented.

Kelly Monroe presents forty-two compelling testimonies from faculty members, former students, and orators at Harvard University whose reflections explode the myth that Christian faith cannot survive a rigorous intellectual environment.

A wide-ranging and authoritative survey of the complex issue of futile medical treatments.

This is a comprehensive major reference work for our SpringerReference program covering clinical trials. Although the core of the Work will focus on the design, analysis, and interpretation of scientific data from clinical trials, a broad spectrum of clinical trial application areas will be covered in detail. This is an important time to develop such a Work, as drug safety and efficacy emphasizes the Clinical Trials process. Because of an immense and growing international disease burden, pharmaceutical and biotechnology companies continue to develop new drugs. Clinical trials have also become extremely globalized in the past 15 years, with over 225,000 international trials ongoing at this point in time. Principles in Practice of Clinical Trials is truly an interdisciplinary that will be divided into the following areas: 1) Clinical Trials Basic Perspectives 2) Regulation and Oversight 3) Basic Trial Designs 4) Advanced Trial Designs 5) Analysis 6) Trial Publication 7) Topics Related Specific Populations and Legal Aspects of Clinical Trials The Work is designed to be comprised of 175 chapters and approximately 2500 pages. The Work will be oriented like many of our SpringerReference Handbooks, presenting detailed and comprehensive expository chapters on broad subjects. The Editors are major figures in the field of clinical trials, and both have written textbooks on the topic. There will also be a slate of 7-8 renowned associate editors that will edit individual sections of the Reference.